MindRank Shares Oral GLP-1RA MDR-001 Clinical Data at LSX World Congress, Emphasizing AI-Driven Innovation
HANGZHOU, China and LONDON, Sept. 18, 2025 — MindRank, a drug discovery company utilizing artificial intelligence (AI) in its clinical stages, presented at the 2025 LSX World Congress in Boston. The company’s keynote presentation, “AI-Designed Oral GLP-1RA: First-in-Class Phase IIb
More